Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom and the United States; - subcontracted manufacturing services (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	160K 183K 147K 138K 259K 17.27M 261K 1.75M 680K 8.51M 688K 673K 29.5M	P/E 2023 *	-	P/E 2024	-77.6x
Enterprise Value	11.63M 13.35M 10.72M 10.08M 18.87M 1.26B 19M 128M 49.54M 620M 50.1M 49.03M 2.15B	EV / Sales 2023	46.6x	EV / Sales 2024	2.39x
Free-Float	95.95%	Yield 2023 *	-	Yield 2024	-

05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan
23-10-16	Safe Orthopaedics Announces Consolidated Sales Results for the Third Quarter and Nine Months of 2023	CI
23-09-06	Safe Group Launches Rehabilitation Proceedings	MT

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE
03-16	SAFE - Modification de la composition du Conseil d'Administration

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Safe Orthopaedics Stock Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	59.21K
STRYKER CORPORATION	+2.21%	+0.71%	-17.54%	+4.57%	115B
SMITH & NEPHEW PLC	+0.13%	-0.35%	+6.14%	-9.80%	12.85B
GLAUKOS CORPORATION	+2.57%	+5.17%	+27.69%	+92.97%	7.48B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.48%	-1.28%	-46.91%	-72.29%	4.06B
DOUBLE MEDICAL TECHNOLOGY INC.	+1.51%	+2.35%	+18.57%	+34.36%	2.52B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.94%	+4.16%	-14.60%	-16.91%	1.76B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.21%	-2.45%	+2.33%	-19.56%	1.6B
L&C BIO CO.,LTD	-7.07%	-4.98%	+170.49%	+141.20%	1.54B
Average	-0.03%	+0.21%	+18.27%	+19.32%	18.41B
Weighted average by Cap.	+1.85%	+0.69%	-11.15%	+7.11%

	2023	2024
Net sales	5.81M 6.67M 5.36M 5.04M 9.42M 628M 9.49M 63.72M 24.75M 310M 25.03M 24.49M 1.07B	5.04M 5.79M 4.65M 4.37M 8.18M 545M 8.23M 55.29M 21.47M 269M 21.72M 21.25M 931M
Net income	-205M -236M -189M -178M -333M -22.22B -336M -2.25B -875M -10.95B -885M -866M -37.96B	-1.93B -2.21B -1.78B -1.67B -3.13B -209B -3.15B -21.16B -8.22B -103B -8.31B -8.13B -356B
Net Debt	270M 310M 249M 234M 439M 29.25B 442M 2.97B 1.15B 14.42B 1.16B 1.14B 49.96B	11.47M 13.17M 10.57M 9.95M 18.61M 1.24B 18.74M 126M 48.86M 611M 49.42M 48.36M 2.12B